company background image
STAR logo

Strides Pharma Science NSEI:STAR Stock Report

Last Price

₹784.70

Market Cap

₹71.2b

7D

3.6%

1Y

169.0%

Updated

28 Mar, 2024

Data

Company Financials +

Strides Pharma Science Limited

NSEI:STAR Stock Report

Market Cap: ₹71.2b

STAR Stock Overview

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally.

STAR fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance0/6
Financial Health2/6
Dividends1/6

Strides Pharma Science Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Strides Pharma Science
Historical stock prices
Current Share Price₹784.70
52 Week High₹838.60
52 Week Low₹285.00
Beta0.78
1 Month Change-2.76%
3 Month Change20.86%
1 Year Change168.96%
3 Year Change-7.70%
5 Year Change58.17%
Change since IPO-12.39%

Recent News & Updates

Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Feb 29
Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Strides Pharma Science Limited's (NSE:STAR) Shares Leap 31% Yet They're Still Not Telling The Full Story

Dec 23
Strides Pharma Science Limited's (NSE:STAR) Shares Leap 31% Yet They're Still Not Telling The Full Story

Recent updates

Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Feb 29
Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Strides Pharma Science Limited's (NSE:STAR) Shares Leap 31% Yet They're Still Not Telling The Full Story

Dec 23
Strides Pharma Science Limited's (NSE:STAR) Shares Leap 31% Yet They're Still Not Telling The Full Story

We Think Strides Pharma Science (NSE:STAR) Is Taking Some Risk With Its Debt

Sep 26
We Think Strides Pharma Science (NSE:STAR) Is Taking Some Risk With Its Debt

Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Jun 08
Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Strides Pharma Science Limited (NSE:STAR) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

Aug 02
Strides Pharma Science Limited (NSE:STAR) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

Is Strides Pharma Science (NSE:STAR) A Risky Investment?

Jun 25
Is Strides Pharma Science (NSE:STAR) A Risky Investment?

Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Dec 21
Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Strides Pharma Science (NSE:STAR) Has Announced That It Will Be Increasing Its Dividend To ₹2.50

Jul 28
Strides Pharma Science (NSE:STAR) Has Announced That It Will Be Increasing Its Dividend To ₹2.50

Estimating The Fair Value Of Strides Pharma Science Limited (NSE:STAR)

Apr 13
Estimating The Fair Value Of Strides Pharma Science Limited (NSE:STAR)

Should Strides Pharma Science Limited (NSE:STAR) Be Part Of Your Dividend Portfolio?

Mar 04
Should Strides Pharma Science Limited (NSE:STAR) Be Part Of Your Dividend Portfolio?

These 4 Measures Indicate That Strides Pharma Science (NSE:STAR) Is Using Debt Extensively

Feb 15
These 4 Measures Indicate That Strides Pharma Science (NSE:STAR) Is Using Debt Extensively

Can Mixed Fundamentals Have A Negative Impact on Strides Pharma Science Limited (NSE:STAR) Current Share Price Momentum?

Jan 26
Can Mixed Fundamentals Have A Negative Impact on Strides Pharma Science Limited (NSE:STAR) Current Share Price Momentum?

The Strides Pharma Science (NSE:STAR) Share Price Is Up 140% And Shareholders Are Boasting About It

Jan 11
The Strides Pharma Science (NSE:STAR) Share Price Is Up 140% And Shareholders Are Boasting About It

Who Has Been Selling Strides Pharma Science Limited (NSE:STAR) Shares?

Dec 28
Who Has Been Selling Strides Pharma Science Limited (NSE:STAR) Shares?

Are Strides Pharma Science's (NSE:STAR) Statutory Earnings A Good Guide To Its Underlying Profitability?

Dec 10
Are Strides Pharma Science's (NSE:STAR) Statutory Earnings A Good Guide To Its Underlying Profitability?

Could The Strides Pharma Science Limited (NSE:STAR) Ownership Structure Tell Us Something Useful?

Nov 25
Could The Strides Pharma Science Limited (NSE:STAR) Ownership Structure Tell Us Something Useful?

Insider Buying: The Strides Pharma Science Limited (NSE:STAR) Non-Executive Director Just Bought 52% More Shares

Aug 17
Insider Buying: The Strides Pharma Science Limited (NSE:STAR) Non-Executive Director Just Bought 52% More Shares

What You Can Learn From Strides Pharma Science Limited's (NSE:STAR) P/E

Aug 11
What You Can Learn From Strides Pharma Science Limited's (NSE:STAR) P/E

Shareholder Returns

STARIN PharmaceuticalsIN Market
7D3.6%2.7%2.5%
1Y169.0%63.9%47.3%

Return vs Industry: STAR exceeded the Indian Pharmaceuticals industry which returned 63.9% over the past year.

Return vs Market: STAR exceeded the Indian Market which returned 47.3% over the past year.

Price Volatility

Is STAR's price volatile compared to industry and market?
STAR volatility
STAR Average Weekly Movement5.6%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.6%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.0%

Stable Share Price: STAR's share price has been volatile over the past 3 months.

Volatility Over Time: STAR's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19902,850Arun Pillaihttps://www.strides.com

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, powders, solids, ointments, and creams.

Strides Pharma Science Limited Fundamentals Summary

How do Strides Pharma Science's earnings and revenue compare to its market cap?
STAR fundamental statistics
Market cap₹71.23b
Earnings (TTM)-₹1.52b
Revenue (TTM)₹39.53b

1.8x

P/S Ratio

-47.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
STAR income statement (TTM)
Revenue₹39.53b
Cost of Revenue₹17.56b
Gross Profit₹21.97b
Other Expenses₹23.50b
Earnings-₹1.52b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-16.59
Gross Margin55.58%
Net Profit Margin-3.86%
Debt/Equity Ratio140.2%

How did STAR perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

-6%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.